S. Verma et al., REACTIVITY OF MESENTERIC-ARTERIES FROM FRUCTOSE HYPERTENSIVE RATS TO ENDOTHELIN-1, American journal of hypertension, 10(9), 1997, pp. 1010-1019
We previously demonstrated that mesenteric arteries from hyperinsuline
mic, insulin resistant fructose hypertensive (FH) rats contain a highe
r absolute amount of ET-1 and exhibit defective endothelium-dependent
vasodilation. Furthermore, chronic ET receptor blockade with bosentan
completely prevented the rise in blood pressure in these rats. The pre
sent study was undertaken to examine 1) whether the reactivity of mese
nteric arteries to ET-1 is altered in FH rats, and 2) whether chronic
bosentan treatment has any effect on ET-1 responsiveness and endotheli
um-dependent vasodilation. Male Sprague Dawley rats were divided into
four groups: control (C), control bosentan-treated (CB), fructose (F)
and fructose bosentan-treated (FB). Chronic oral bosentan treatment (1
00 mg/kg/day) was initiated in the CB and FB groups 1 week prior to in
itiating the fructose diet. At week 16, the F group was hyperinsulinem
ic and hypertensive when compared to the C group (plasma insulin: 5.8
+/- 0.3 v C 3.2 +/- 0.5 ng/mL, P <.001; systolic BP: 157 +/- 5 v C 130
+/- 4 mm Hg, P <.001). Treatment of the F group with bosentan prevent
ed the rise in BP (FB: 133 +/- 3 mm Hg; P <.001 v Fl. Analysis of the
pressurized mesenteric resistance arterioles demonstrated that the wal
l thickness as expressed as percentage of internal diameter did not di
ffer between arteries from C and F rats, when measured over a range of
transmural pressures. Constrictor responses of resistance arterioles
to NE were similar for C and F rats when studied at transmural pressur
es of either 120 mm Hg or 160 mm Hg, respectively. The maximum contrac
tile response and the sensitivity of superior mesenteric arteries to N
E did not differ between the groups, either with or without the endoth
elium. However, the maximum contractile response to ET-1 was depressed
in the F group both with (+) and without (-) the endothelium [(+): 1.
50 +/- 0.11 v C 1.88 +/- 0.1 g/mm(3), P <.05, (-): 1.68 +/- 0.11 v C 2
.05 +/- 0.1 g/mm(3), P <.05.]. Furthermore, the endothelium intact F a
rteries exhibited a decreased sensitivity to ET-1 (pD(2) values F 8.36
+/- 0.11 v C 8.83 +/- 0.07). Chronic bosentan treatment of the F grou
p restored the maximum tension responses of arteries to ET-1 [(+) in t
he FB group: 1.88 +/- 0.12 g/mm(3) v C, P >.05, (-): 1.95 +/- 0.05 g/m
m(3) v C, P >.05] but had no effect on the responses of the CB group.
In arteries with intact: endothelium, bosentan treatment restored the
sensitivity of the F arteries to ET-1 (pD(2) values FB 8.82 +/- 0.05 v
C, P <.05). Endothelium-dependent relaxation responses were diminishe
d in the F group, which were unaffected by bosentan treatment. These d
ata suggest that mesenteric arteries from FH demonstrate a specific al
teration towards the reactivity to ET-1, which is restored by long-ter
m bosentan treatment. (C) 1997 American Journal of Hypertension, Ltd.